ALL

MD IQ

News

CAR T-cell studies to be presented at ASH

Several studies set to be presented at the 2018 ASH Annual Meeting provide new insights regarding chimeric antigen receptor (CAR) T-cell therapies...

News

CHMP backs blinatumomab for MRD

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding marketing authorization for...

News

Cost-effectiveness of CAR T-cell therapy

Tisagenlecleucel has the potential to be cost-effective for pediatric B-cell acute lymphoblastic leukemia (B-ALL) patients in the United States,...

Pages